Correlation Between Enanta Pharmaceuticals and Traws Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Traws Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Traws Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Traws Pharma, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Traws Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Traws Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Traws Pharma.

Diversification Opportunities for Enanta Pharmaceuticals and Traws Pharma

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Enanta and Traws is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Traws Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Traws Pharma and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Traws Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Traws Pharma has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Traws Pharma go up and down completely randomly.

Pair Corralation between Enanta Pharmaceuticals and Traws Pharma

Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to under-perform the Traws Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Enanta Pharmaceuticals is 2.51 times less risky than Traws Pharma. The stock trades about -0.42 of its potential returns per unit of risk. The Traws Pharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  500.00  in Traws Pharma on September 5, 2024 and sell it today you would earn a total of  18.00  from holding Traws Pharma or generate 3.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Enanta Pharmaceuticals  vs.  Traws Pharma

 Performance 
       Timeline  
Enanta Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enanta Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Traws Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Traws Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Enanta Pharmaceuticals and Traws Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enanta Pharmaceuticals and Traws Pharma

The main advantage of trading using opposite Enanta Pharmaceuticals and Traws Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Traws Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Traws Pharma will offset losses from the drop in Traws Pharma's long position.
The idea behind Enanta Pharmaceuticals and Traws Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance